Enhanced therapeutic efficacy of platinum-doxorubicin nanoparticles on colon and breast cancer cell lines
Crossref DOI link: https://doi.org/10.1007/s00210-025-04080-4
Published Online: 2025-04-29
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Kalındemirtaş, Ferdane Danışman
Cilasun, Gökçe Erdemir
Kariper, Afşin
Text and Data Mining valid from 2025-04-29
Version of Record valid from 2025-04-29
Article History
Received: 29 December 2024
Accepted: 19 March 2025
First Online: 29 April 2025
Declarations
:
: The authors declare no competing interests.